PT-141 (Bremelanotide): A Research Overview of Melanocortin Receptor Agonism and Published Clinical Data
PT-141, also known by its pharmaceutical name bremelanotide, is a synthetic peptide that acts as an agonist at melanocortin receptors — a family of G-protein coupled receptors that regulate multiple physiological processes including pigmentation, energy metabolism, and sexual function. PT-141 holds a notable position in the research peptide literature because it has progressed through clinical […]